Skip to content

Edge of Laminar Block Versus Erector Spinae Plane Block for Postoperative Analgesia in Video-Assisted Thoracoscopic Surgery

Ultrasound-Guided Edge of Laminar Block Versus Erector Spinae Plane Block for Postoperative Analgesia in Patients Undergoing Video-Assisted Thoracoscopic Surgery: A Randomized Clinical Trial

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07201285
Enrollment
70
Registered
2025-10-01
Start date
2025-10-01
Completion date
2026-04-12
Last updated
2026-04-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Edge of Laminar Block, Erector Spinae Plane Block, Postoperative Analgesia, Video-Assisted Thoracoscopic Surgery

Brief summary

This study aims to compare the ultrasound-guided edge of laminar block (ELB) and erector spinae plane block (ESPB) for postoperative analgesia in patients undergoing video-assisted thoracic surgery (VATS).

Detailed description

Postoperative pain after thoracic surgery, which is attributed to muscle incisions, rib retractions, and intercostal nerve damage, may be severe enough to cause pulmonary complications, such as atelectasis, pneumonia, and increased oxygen consumption. The erector spinae plane block (ESPB) is used for managing post-thoracotomy pain and has numerous advantages that make it an attractive alternative technique. The ESPB injects a local anaesthetic around the erector spinae muscle at approximately the level of the T5. It may be able to block the dorsal and ventral rami of the thoracic spinal nerves. A novel technique of retrolaminar block (RLB) called the edge of laminar block (ELB) to provide sensory analgesia during rib fracture surgery.

Interventions

OTHEREdge of laminar block

Patients will receive edge of laminar block using 20ml of bupivacaine 0.25%.

OTHERErector spinae plane block

Patients will receive an erector spinae plane block using 20ml of bupivacaine 0.25%.

Sponsors

Tanta University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Age from 18 to 65 years. * Both sexes. * American Society of Anesthesiology (ASA) physical status I-II. * Undergoing video-assisted thoracic surgery (VATS) under general anesthesia.

Exclusion criteria

* History of allergies to local anesthetics. * Opioid dependency. * Bleeding or coagulation disorders. * Psychiatric and neurological disorder. * Local infection at the site of injection. * Severe heart, lung, liver, and renal dysfunction. * Pregnant or lactating women.

Design outcomes

Primary

MeasureTime frameDescription
Total morphine consumption24 hours postoperativelyRescue analgesia of morphine will be given as 3 mg bolus if the numeric rating scale (NRS)\> 3 to be repeated after 30 min if pain persists until the NRS \< 4.

Secondary

MeasureTime frameDescription
Time to the 1st rescue analgesia24 hours postoperativelyTime to the first request for the rescue analgesia (time from the end of surgery to first dose of morphine administrated).
Intraoperative fentanyl consumptionIntraoperativelyAdditional fentanyl bolus dosages of 0.5 µg/kg IV will be administered if heart rate or mean arterial blood pressure elevated more than 20% of the baseline.
Heart rateTill the end of surgery (Up to 2 hours)Heart rate will be recorded preoperatively, before performing of block, and every 15 min till the end of surgery.
Mean arterial pressureTill the end of surgery (Up to 2 hours)Mean arterial pressure will be recorded preoperatively, before performing of block, and every 15 min till the end of surgery.
Degree of pain24 hours postoperativelyEach patient will be instructed about postoperative pain assessment with the numeric rating scale (NRS). NRS (0 represents "no pain" while 10 represents "the worst pain imaginable"). NRS will be assessed at post-anesthesia care unit (PACU), 2, 4, 6, 8, 12, 18, and 24 h postoperatively.
Incidence of adverse events24 hours postoperativelyIncidence of adverse events such as bradycardia, hypotension, nausea, vomiting, respiratory depression, pruritus, urinary retention, itching, constipation, or any other complication.

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 23, 2026